Dose Finding Phase 1 Study of the Treatment of Metastatic Melanoma With MPC-6827 in Combination With Temozolomide.

Trial Profile

Dose Finding Phase 1 Study of the Treatment of Metastatic Melanoma With MPC-6827 in Combination With Temozolomide.

Completed
Phase of Trial: Phase I

Latest Information Update: 19 Aug 2010

At a glance

  • Drugs Temozolomide; Verubulin
  • Indications Cancer metastases; Malignant melanoma
  • Focus Adverse reactions
  • Most Recent Events

    • 19 Aug 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 20 May 2010 Final data will be reported at ASCO 2010, according to a Myriad Pharmaceuticals media release.
    • 18 Nov 2009 Initial results have been announced by Myriad in a media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top